Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc., (NYSE: ARE) is a leading real estate investment trust (REIT), focused on providing the highest-quality urban office buildings for life science, technology, and agtech companies in AAA innovation cluster locations. Founded in 1994, Alexandria has established a presence in some of the most in-demand markets, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle.

Alexandria’s total market capitalization as of December 31, 2020, stood at $31.9 billion. Its asset base in North America was 49.7 million square feet (RSF). Alexandria’s portfolio includes 31.9 million RSF of operating properties, 3.3 million RSF of Class A properties undergoing construction, 7.1 million RSF of near-term and intermediate-term development and re-development projects and 7.4 million SF of future development projects.

The company is focused on providing collaborative and dynamic workspaces for its tenants, which allows them to attract world-class talent and increase productivity and efficiency. Additionally, Alexandria also provides venture capital to transformative life science, technology and agtech companies through its venture capital platform. This comprehensive model of strategic capital and quality workspaces has enabled Alexandria to achieve higher occupancy levels, longer lease terms, higher rental income and higher returns, resulting in greater long-term asset value.

Alexandria’s long-standing track record of success has enabled it to become one of the most successful REITs in the sector. In 2019, Alexandria was ranked the “#1 Top Performing Stock” by the Wall Street Journal, and was ranked #15 overall on the 2020 S&P 500 Top Performers list. Additionally, Alexandria has been included in the S&P 500 since 2011, and is the only life science real estate company listed on the index.